First-line therapy with rituximab may lower mortality risk in RA patients with lung conditions
Patients with rheumatoid arthritis who also have lung involvement often have increased mortality, but first-line therapy with rituximab may help them live longer when compared with the use of TNF inhibitors , according to ...
Nov 13, 2016
0
0